image
image
user-login
arrow
Cipran AYUGEN PHARMA PVT. LTD.
Cipran

Cipran
AYUGEN PHARMA PVT. LTD.

Cipran is a Trademark filed on Mar 01, 2012 in through IP Office.The Trademark is registered to AYUGEN PHARMA PVT. LTD. and was filed by attorney.

Cipran

Cipran AYUGEN PHARMA PVT. LTD. Trademark Information

Application ID

2292121

Status

Registered

Date of Application

Mar 01, 2012

Classes

31

Proprietor(s)

AYUGEN PHARMA PVT. LTD.

Published

Mar 25, 2013

Used Since

01/03/2012

Valid/Upto

01/03/2022

Related trademark

CIPRAN RICHE LABORATORIED LTD.

Abandoned

Class -5
CIPRAN SUNIL A. MAHADIK

Objected

Class -5

FAQs

The application for Cipran was made on Mar 01, 2012
The trademark applicant for Cipran is AYUGEN PHARMA PVT. LTD..
Trademark application has been filed under the class(es) 31.
As per IP India, trademark application is on the following stage: Registered.
Listed application Id of Cipran is 2292121.
Cipran Trademark is a undefined mark.
Disclaimer: Vakilsearch assumes no responsibility or liability for any errors or omissions in the content of this page. The data is derived from mca.gov.in and ipindia.gov.in
bulb
Don’t lose your brand like ”
Our experts are here to assist you in finding a similar trademark.
  • No results found
1 Lakh+
TM Registered since 2011
trademark
star
4.5/5
(19k+ reviews)
google

footer-service

By continuing past this page, you agree to our Terms of Service Cookie Policy Privacy Policy  and  Refund Policy  © - Uber9 Business Process Services Private Limited. All rights reserved.

Uber9 Business Process Services Private Limited, CIN - U74900TN2014PTC098414, GSTIN - 33AABCU7650C1ZM, Registered Office Address - F-97, Newry Shreya Apartments Anna Nagar East, Chennai, Tamil Nadu 600102, India.

Please note that we are a facilitating platform enabling access to reliable professionals. We are not a law firm and do not provide legal services ourselves. The information on this website is for the purpose of knowledge only and should not be relied upon as legal advice or opinion.